South Korean skincare brand IOPE has entered the Canadian market through an exclusive retail partnership with Sephora Canada, marking its first expansion into the country as part of a broader North American growth strategy.
The clinical-grade skincare brand, owned by Amorepacific, launched online at Sephora.com recently and in Sephora stores nationwide.
The move signals continued momentum in the Canadian beauty retail sector, as international brands look to tap demand for innovation-driven skincare products rooted in clinical research and dermatological science.
“We’re excited to be adding IOPE to our Canadian assortment. As a lab-based skincare brand, IOPE focuses on bioscience and dermatology to address aging and skin health. With decades of research and a legacy rooted in innovation, IOPE brings a refined approach to high-performance skincare,” said Jane Nugent, SVP, Merchandising, Sephora Canada. “We’re proud to partner exclusively on this launch, continuing our commitment to bringing globally iconic Korean skincare brands to our clients.”
Founded in 1996, IOPE said it has built its reputation on clinical testing and ingredient research tied to anti-aging formulations. The company cited advancements in active ingredients such as PDRN, stabilized Vitamin C and retinol stabilization technology, supported by dozens of patents in Korea and scientific publications.
The brand positions its formulations as bridging in-clinic cosmetic treatments and daily skincare routines, with products designed to address concerns such as skin texture, firmness, brightness and overall vitality.
IOPE is entering Canada with nine products across several collections, including XMD, Retinol RX™, Vitamin C and PDRN. The company said its newest launches are inspired by skin booster treatments that have gained widespread attention in Korea.
Among the products is the XMD Stem III Clinical Recovery Serum, priced at $80. The company said the serum was clinically tested to deliver treatment-level results across multiple performance measures, including skin elasticity, texture and volume, while avoiding the discomfort associated with in-office procedures.
Another launch is the Retinol RX™ 2% Reti-jection Serum, priced at $77. The product features the brand’s proprietary retinoid complex and is designed to balance effectiveness with reduced irritation compared with traditional retinol formulas. IOPE said the serum incorporates retinol-infused spicules intended to improve absorption and that a four-week clinical study showed improvements in the appearance of wrinkles, pores and skin radiance.
The company also plans to expand its Canadian assortment with additional products, including the Retinol RX™ 1% Super Bounce Serum, the Vitamin C 40% Concentrate Cream and the PDRN Caffeine Shot Serum. IOPE said these products are formulated to target specific skincare concerns such as smoothing, depuffing and rejuvenation.
Across its Canadian lineup, IOPE products range in price from $9 for a single sheet mask to $93 for the XMD Stem III Clinical Recovery Cream.
The Canadian launch represents a step in IOPE’s broader strategy to introduce what it describes as high-performance skincare innovations to new markets.
The brand said it intends to build on its initial entry with further product introductions aimed at advancing anti-aging skincare standards in Canada.
More from Retail Insider:
